The Efficacy of Hybrid Vaginal Ovules for Co-Delivery of Curcumin and Miconazole against Candida albicans
-
Published:2024-02-23
Issue:3
Volume:16
Page:312
-
ISSN:1999-4923
-
Container-title:Pharmaceutics
-
language:en
-
Short-container-title:Pharmaceutics
Author:
Bezerra Brenda Maria Silva1ORCID, y Araújo Sara Efigênia Dantas de Mendonça1ORCID, Alves-Júnior José de Oliveira2ORCID, Damasceno Bolívar Ponciano Goulart de Lima12, Oshiro-Junior João Augusto12ORCID
Affiliation:
1. Pharmaceutical Sciences Postgraduate Program, Center for Biological and Health Sciences, State University of Paraíba, Av. Juvêncio Arruda, S/N, Campina Grande 58429-500, PB, Brazil 2. Department of Pharmacy, Center for Biological and Health Sciences, State University of Paraíba, Av. Juvêncio Arruda, S/N, Campina Grande 58429-500, PB, Brazil
Abstract
Curcumin (CUR) is a natural compound that can be combined with miconazole (MCZ) to improve vulvovaginal candidiasis (VVC) caused by Candida albicans treatment’s efficacy. This study aimed to develop ureasil–polyether (U-PEO) vaginal ovules loaded with CUR and MCZ for the treatment of VVC. Physicochemical characterization was performed by thermogravimetry (TGA), differential thermal analysis (DTA), Fourier transform infrared spectroscopy (FTIR), and in vitro release. Antifungal assays were used to determine minimum inhibitory concentrations (MICs) and synergism between CUR and MCZ, and the activity of U-PEO ovules were performed by microdilution and agar diffusion. TGA results showed high thermal stability of the hybrid ovules. In DTA, the amorphous character of U-PEO and a possible interaction between CUR and MCZ were observed. FTIR showed no chemical incompatibility between the drugs. In vitro release resulted in 80% of CUR and 95% of MCZ released within 144 h. The MICs of CUR and MCZ were 256 and 2.5 µg/mL, respectively. After combining the drugs, the MIC of MCZ decreased four-fold to 0.625 µg/mL, while that of CUR decreased eight-fold to 32 µg/mL. Synergism was confirmed by the fractional inhibitory concentration index (FICI) equal to 0.375. U-PEO alone showed no antifungal activity. U-PEO/MCZ and U-PEO/CUR/MCZ ovules showed the greatest zones of inhibition (≥18 mm). The results highlight the potential of the ovules to be administered at a lower frequency and at reduced doses compared to available formulations.
Reference55 articles.
1. Czechowicz, P., Nowicka, J., and Gościniak, G. (2022). Virulence Factors of Candida spp. and Host Immune Response Important in the Pathogenesis of Vulvovaginal Candidiasis. Int. J. Mol. Sci., 23. 2. Willems, H.M.E., Ahmed, S.S., Liu, J., Xu, Z., Peters, B.M., Willems, H., Ahmed, S., Liu, J., Xu, Z., and Peters, B. (2020). Vulvovaginal Candidiasis: A Current Understanding and Burning Questions. J. Fungi, 6. 3. Yano, J., Sobel, J.D., Nyirjesy, P., Sobel, R., Williams, V.L., Yu, Q., Noverr, M.C., and Fidel, P.L. (2019). Current Patient Perspectives of Vulvovaginal Candidiasis: Incidence, Symptoms, Management and Post-Treatment Outcomes. BMC Women’s Health, 19. 4. Antifungal therapy: New and evolving therapies;Ledoux;Semin. Respir. Crit. Care Med.,2020 5. Stenkiewicz-Witeska, J.S., and Ene, I.V. (2023). Azole potentiation in Candida species. PLoS Pathog., 19.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|